stronger warnings to avoid mycophenolate (CellCept, Myfortic) during pregnancy

December 2007

Please see updated information from the FDA

You'll see stronger warnings to avoid mycophenolate (CellCept, Myfortic) during pregnancy.

This is due to new evidence of a higher risk of miscarriage and birth defects in women taking mycophenolate to prevent transplant rejection.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

12 issues every year, with brief articles about new meds and hot topics
200+ CE courses, including the popular CE-in-the-Letter
Quick reference drug comparison charts
Access to the entire archive

Subscribe Today!

Already a subscriber? Log in

Volume pricing available. Get quote

Table of Contents

people will become victims of medical identity theft
Diabetes new prescribing restrictions for rosiglitazone
Gastroenterology drugs surprise patients by causing esophageal pain
Men's Health possible hearing loss with the erectile dysfunction drugs (Viagra, etc)
Infectious Diseases Daptomycin (Cubicin) is a new IV antibiotic
Respiratory & Allergy Avamys (AV-uh-miss) will be a new option for treating seasonal allergic rhinitis
Women's Health how to choose the right oral contraceptive
Women's Health stronger warnings to avoid mycophenolate (CellCept, Myfortic) during pregnancy
Neurology & Pain what to use for low back pain
Psychiatry psychiatric problems and serious allergic reactions with modafinil (Alertec)
Rheumatology More patients will get hydroxychloroquine (Plaquenil, etc) for systemic lupus erythematosus
Supplements A controversy is brewing over the natural sweetener, stevia
Substance Use Disorder Suboxone is a new sublingual tablet to treat opioid dependence
Cardiology when it's better to use an ACE inhibitor or an angiotensin receptor blocker (ARB)
Practice End of year is a good time to reflect on trustworthy drug information that is relevant to practice